Baby diagnosed with rare early puberty after health visitor spots unusual breast development

A London mother says her 10-month-old daughter’s unexpected diagnosis has brought hormone treatment, regular monitoring and difficult questions about her future.

Sophie Dumas says her life changed when a health visitor noticed that her baby daughter’s breast tissue looked unusually developed. What followed was a referral to specialists, a series of tests and a diagnosis that few parents ever expect to hear: central precocious puberty, or CPP, in a child who was only 10 months old. Dumas, who lives in London, says she had not realised anything was wrong before the health visitor raised the alarm, in part because babies can naturally carry soft tissue around the chest and because her daughter was still breastfed.

Doctors then carried out hormone testing and an MRI scan to rule out an underlying brain abnormality, which can sometimes trigger CPP. According to the Mayo Clinic and Cleveland Clinic, that diagnostic process typically includes a physical examination, blood tests to measure hormone levels, bone-age monitoring and imaging when specialists want to exclude structural causes. In Sienna’s case, the scan was clear, leaving the family with a diagnosis that is uncommon, emotionally difficult and, in many cases, without a known cause.

Specialists told the family that treatment would involve regular injections of a gonadotropin-releasing hormone analogue, or GnRH analogue, a medication used to slow or stop the hormonal signals that drive puberty. The condition is more often seen in girls, and MedlinePlus Genetics says puberty normally begins much later, usually between the ages of 8 and 13 in girls. If untreated, early puberty can shorten adult height because bones mature too soon, and reviews in The Lancet Child & Adolescent Health and the National Center for Biotechnology Information say therapy is generally aimed at preserving height and reducing psychological strain as children grow.

Dumas says she is already thinking ahead to her daughter’s future, including whether egg freezing might one day be worth considering if fertility becomes a concern. That is not part of standard treatment for CPP, but it reflects the uncertainty many parents feel when a child is diagnosed so young. Specialists usually monitor growth, bone age and development over time, and in Sienna’s case doctors expect treatment to continue until she is around 11 or 12, depending on how she progresses.

For now, Dumas says she is trying to shield her daughter from the pressures that can come with early physical changes. Sienna has also started dealing with hormonal spots, which have led to comments from other children at school, and her mother says that has been upsetting. She says the family’s experience has reinforced how important it is for parents to seek medical advice if something seems unusual, even when they are unsure whether their concerns will be taken seriously.